A detailed history of Marble Harbor Investment Counsel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Marble Harbor Investment Counsel, LLC holds 193,802 shares of ABBV stock, worth $33 Million. This represents 4.35% of its overall portfolio holdings.

Number of Shares
193,802
Previous 193,783 0.01%
Holding current value
$33 Million
Previous $33.2 Million 15.15%
% of portfolio
4.35%
Previous 4.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $3,112 - $3,787
19 Added 0.01%
193,802 $38.3 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $121,974 - $142,438
-788 Reduced 0.4%
193,783 $33.2 Million
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $191,624 - $218,337
-1,199 Reduced 0.61%
194,571 $35.4 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $987,968 - $1.11 Million
-7,180 Reduced 3.54%
195,770 $30.3 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $148,552 - $171,970
-1,112 Reduced 0.54%
202,950 $30.3 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $113,958 - $141,814
-860 Reduced 0.42%
204,062 $27.5 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $65,797 - $75,775
-455 Reduced 0.22%
204,922 $32.7 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $556,697 - $667,626
4,025 Added 2.0%
205,377 $33.2 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $180,512 - $207,035
-1,345 Reduced 0.66%
201,352 $27 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $7,293 - $9,272
-53 Reduced 0.03%
202,697 $31 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $384,721 - $477,331
-2,915 Reduced 1.42%
202,750 $32.9 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $23,634 - $29,904
-220 Reduced 0.11%
205,665 $27.8 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $127,148 - $144,332
1,195 Added 0.58%
205,885 $22.2 Million
Q2 2021

Aug 09, 2021

SELL
$105.21 - $117.21 $217,784 - $242,624
-2,070 Reduced 1.0%
204,690 $23.1 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $329,917 - $363,199
-3,225 Reduced 1.54%
206,760 $22.4 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $57,630 - $77,807
716 Added 0.34%
209,985 $22.5 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $437,367 - $513,325
-5,091 Reduced 2.37%
209,269 $18.3 Million
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $519,386 - $695,016
-7,079 Reduced 3.2%
214,360 $21 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $113,842 - $172,599
-1,765 Reduced 0.79%
221,439 $16.9 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $363,246 - $454,499
5,036 Added 2.31%
223,204 $19.8 Million
Q3 2019

Nov 06, 2019

BUY
$62.98 - $75.72 $1.52 Million - $1.83 Million
24,145 Added 12.44%
218,168 $16.5 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $88,695 - $113,373
1,350 Added 0.7%
194,023 $14.1 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $40,112 - $47,210
-520 Reduced 0.27%
192,673 $15.5 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $62,747 - $77,384
-806 Reduced 0.42%
193,193 $17.8 Million
Q3 2018

Nov 06, 2018

SELL
$88.91 - $98.84 $29,518 - $32,814
-332 Reduced 0.17%
193,999 $18.3 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $230,555 - $272,798
-2,568 Reduced 1.3%
194,331 $18 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $158,349 - $212,044
-1,721 Reduced 0.87%
196,899 $18.6 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $174,104 - $190,920
-1,944 Reduced 0.97%
198,620 $19.2 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $14 Million - $17.9 Million
200,564
200,564 $17.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Marble Harbor Investment Counsel, LLC Portfolio

Follow Marble Harbor Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marble Harbor Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marble Harbor Investment Counsel, LLC with notifications on news.